Predictive factors for work‐day loss in Behçet's syndrome: A multi‐center study. (19th December 2019)

• Record Type: Journal Article
• Authors: Mumcu, Gonca; Yay, Meral; Aksoy, Aysun; Taş, Mehmet Nedim; Armağan, Berkan; Sarı, Alper; Bozca, Burçin Cansu; Tekgöz, Emre; Karadağ, Duygu Temiz; Badak, Suade Özlem; Tecer, Duygu; Bes, Cemal; Şahin, Ali; Erken, Eren; Cefle, Ayse; Çınar, Muhammet; Yılmaz, Sedat; Karaçaylı, Ümit; Alpsoy, Erkan; Şenel, Soner; Yaşar Bilge, Şule; Kaşifoğlu, Timuçin; Karadağ, Ömer; Aksu, Kenan; Keser, Gökhan; Alibaz‐Öner, Fatma; İnanç, Nevsun; Ergun, Tülin; Direskeneli, Haner
• Is Part Of: International journal of rheumatic diseases. Volume 23:Number 2(2020)
• Page Start: 240
• Page End: 246
• Publication Date: 2019-12-19
• Subjects: Behçet's disease -- ocular involvement -- vascular involvement -- work‐day loss; Rheumatology -- Periodicals; Rheumatology -- Asia -- Periodicals; Rheumatology -- Pacific Area -- Periodicals; Rheumatic Diseases -- Periodicals; Connective Tissue Diseases -- Periodicals; Immune System Diseases -- Periodicals; 616.723
• DOI: 10.1111/1756-185X.13771
• Languages: English
• ISSNs: 1756-1841

Abstract

Abstract: Objective: The aim of this multi‐center study was to assess predictive factors for work‐day loss as an indirect cost element in Behçet's syndrome (BS). Methods: In this cross‐sectional, multi‐center study, 834 BS patients (F/M: 441/393, age mean: 38.4 ± 10.9 years) were included. Data were collected by a questionnaire regarding treatment protocols, disease duration, smoking pattern, frequency of medical visits during the previous year and self‐reported work‐day loss during the previous year. Results: Work‐day loss was observed in 16.2% of patients (M/F: 103/32). The percentages of being a smoker (81.8%), using immunosuppressive (IS) medications (82%), and having disease duration <5 years (74%) were higher in male patients with work‐day loss ( P < .05). The majority of males (90.9%) had more than four clinic visits during the previous year. Moreover, the mean work‐day loss (30.8 ± 57.7 days) was higher in patients with vascular involvement (56.1 ± 85.9) than those without (26.4 ± 50.6 days) ( P = .046). In addition, increased frequency of ocular involvement (25.9%) was also observed in patients with work‐day loss compared to others (8.6%) ( P = .059). Conclusion: Work‐day loss was associated with both vascular and ocular involvement. Close associations were observed among male gender, early period of the disease, frequent medical visits, being a smoker and treatment with IS medications in patients with work‐day loss.